Drugmaker, Sanofi-aventis | featured news

Sanofi launches hostile $18.5 billion bid for Genzyme

French drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate.

<

 

Subscribe to this RSS topic: Syndicate content